XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue:    
Total revenue $ 894 $ 0
Operating expenses:    
Research and development 71,979 30,275
Sales and marketing 6,938 3,041
General and administrative 27,469 27,286
Total operating expenses 106,386 60,602
Loss from operations (105,492) (60,602)
Other income (expenses), net:    
Interest income (expense), net 2,187 (1,886)
Gain (loss) on revaluation of warrant liabilities 24,475 (37,584)
Loss on revaluation of derivative liabilities 0 (223,165)
Gain (loss) on revaluation of earnout liabilities 1,313 (154,806)
Other (expenses) income, net (452) 926
Total other income (expenses), net 27,523 (416,515)
Net loss to common stockholders (77,969) (477,117)
Comprehensive loss to common stockholders $ (77,969) $ (477,117)
Net loss per share, basic (in USD per share) $ (0.51) $ (5.73)
Net loss per share, diluted (in USD per share) $ (0.51) $ (5.73)
Weighted average shares used in per share calculation, basic (in shares) 152,676,155 83,256,431
Weighted average shares used in per share calculation, diluted (in shares) 152,676,155 83,256,431
Revenue    
Revenue:    
Total revenue $ 610 $ 0
Revenue - related parties    
Revenue:    
Total revenue $ 284 $ 0